XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Notes Payable and Advances-related parties
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Notes Payable and Advances-related parties
Note 5.              Notes Payable and Advances-related parties
 
Notes payable to unrelated parties consist of:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
 
 
(Unaudited)
 
 
 
 
Robert Shaw, $25,000 Promissory Note issued September 20, 2001; interest rate
     9% per annum, due December 20, 2001.
 
 
15
 
 
15
 
 
 
 
 
 
 
 
 
Ventana Medical Systems, Inc. $62,946 Promissory Note issued November 30, 2003;
     due December 31, 2003; interest rate 8% per annum payable
     after December 31, 2003
 
 
21
 
 
21
 
 
 
 
 
 
 
 
 
Xillix Technologies Corporation $361,000 Promissory Note issued June 26, 1998;
     Interest rate Canadian Prime plus 6% per annum, due December 27, 1999;
     represents a debt of AccuMed
 
 
 
 
34
 
 
 
$
36
 
$
70
 
 
 
During the nine months ended September 30, 2013, the Company liquidated AccuMed, its wholly owned subsidiary. As a result, the note and accrued interest totaling $73,000 due to Xillex Technologies Corporation was recorded as a reduction in selling, general and administration expense.                                                                                                                           
 
                The Company has failed to make principal and interest payments when due and is in breach of certain warranties and representations under the notes included above.  Such notes require the holder to notify the Company in writing of a declaration of default at which time a cure period, as specified in each individual note, would commence.  The Company has not received any written declarations of default from holders of its remaining outstanding notes payable. 
 
                During the nine months ended September 30, 2013, the Company was advanced $145,000 from a related party. These advances are non-interest bearing and are due on demand. However, using an 8% annual interest rate, the Company has recorded a non-cash interest expense totaling approximately $96,000 on the outstanding balance for the nine months ended September 30, 2013.